Celltheon Corporation

Celltheon Corporation

Biotechnology Research

Union City, CA 2,340 followers

Global leader in Cell Line Development for Next Generation Bio-therapeutics

About us

About Us: Located in the San Francisco Bay Area, Celltheon has been developing Cell Engineering technologies since 2012. Celltheon has patents, granted and pending, for its CHOK-1 derived SUPERCELL™ cell line and its unique DNA and RNA vector elements that are applicable for recombinant biotherapeutics such as Mabs, Difficult to Express Proteins (DEP) as well as for CAR-T, Gene Therapy and Cell Factories applications. Serving the Biotherapeutics Industry with Innovation & Dedication The CELLTHEON SMART™ Platform has been used to date in 60+ biotherapeutics for oncology, neurobiology and RA programs. In 2018 Celltheon formed strategic partnerships with industry leading companies to offer end-to-end cDNA to manufacturing solutions: scale-up process equipment, cell culture media and analytical screening tools for developing process based on Quality-By-Design (QBD). Combined with our industry leading Celltheon SMARTTM Platform and our deep knowhow, we provide Cell Line and Process Development services to make your most difficult to express therapeutic proteins commercially viable: • Antibody fragments • Difficult to express proteins • Fc-fusion proteins • mAbs CELLTHEON SMART™ PLATFORM  Reduces timelines  Lowers costs  Increases efficiencies  Ensures consistent product quality  Improves and accelerates decision-making CELLTHEON TECHNOLOGY HIGHLIGHTS  CELLTHEON SMART™ Platform enables commercial viability of Hard to Express Proteins  Celltheon SUPERCELL™ metabolic profile optimal for CQAs  CT-STABILIZER™ element results in clones with high generational stability (>120)  CT-STABILIZER™ element results in Qp as high as 60 pg/cell/day and robust/repeatable processes  CT-STABILIZER™ element results in high number of high-expressing clones  Provides robust & repeatable cDNA to scale-up workflow  Built in Quality By Design gives consistently high titer clones  CELLTHEON’s consistent CQAs at every scale gives you confidence in the success of your program

Industry
Biotechnology Research
Company size
11-50 employees
Headquarters
Union City, CA
Type
Privately Held
Founded
2012
Specialties
Cell line development, BioProduction, Hard To Express Proteins, QBD, Transient Expression, Stable Pools, Matching CQAs, Upstream PD, Downstream PD, RCB, Cell Based Assays, 3L Bio processing, 50L Scale up, 200L Scale up, Short timelines, Qp >50-60pcd, Titers >6-7gm/L, and 8-10 Weeks to RCB

Locations

  • Primary

    32980 Alvarado Niles Road, Suite 826

    Union City, CA 94587, US

    Get directions

Employees at Celltheon Corporation

Updates

  • I am excited to share a quick preview of the engaging discussions coming up at Biologics Conference 2025! I will be speaking in the session on Cell Line Development: Driving Innovation from Engineering to Manufacturing. Join us in Goa this January as we explore cutting-edge advancements, next-generation cell engineering technologies, and the critical role of Indo-U.S. partnerships in transforming biologics manufacturing. Don’t miss out! Last few passes remaining — register now to be part of shaping the future of biopharma! 📅 January 30-31, 2025 📍 Novotel Dona Sylvia Resort, Goa, India hashtag #Biologics2025 hashtag #Biopharma hashtag #CellLineDevelopment hashtag #Innovation hashtag #GlobalPartnerships hashtag #Healthcare hashtag #Leadership Follow We’re thrilled to welcome Amita Goel, CEO of Celltheon Corporation as a speaker at 𝐁𝐢𝐨𝐥𝐨𝐠𝐢𝐜𝐬 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 2025 in our session on ‘𝐂𝐞𝐥𝐥 𝐋𝐢𝐧𝐞 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭: 𝐃𝐫𝐢𝐯𝐢𝐧𝐠 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧 𝐟𝐫𝐨𝐦 𝐄𝐧𝐠𝐢𝐧𝐞𝐞𝐫𝐢𝐧𝐠 𝐭𝐨 𝐌𝐚𝐧𝐮𝐟𝐚𝐜𝐭𝐮𝐫𝐢𝐧𝐠’. Her talk will focus on next-generation hashtag #cell engineering technologies with an emphasis on the role of 𝐈𝐧𝐝𝐨-𝐔.𝐒. 𝐩𝐚𝐫𝐭𝐧𝐞𝐫𝐬𝐡𝐢𝐩𝐬 in advancing hashtag #biologics development. Join us at hashtag #Biologics2025 to gain an in-depth understanding of how hashtag #global partnerships are accelerating hashtag #breakthroughs in biologics development and paving the way for more accessible hashtag #healthcare solutions. #Register today and make the most of this incredible opportunity to engage with hashtag #industry leaders and experts shaping the future of hashtag #biologics! https://lnkd.in/dSVTT_gT 📅 Save the Date: January 30-31, 2025 📍 Location: Novotel Dona Sylvia Resort, Goa, India 🌴 LAST FEW PASSES LEFT >>> 𝐒𝐞𝐜𝐮𝐫𝐞 𝐲𝐨𝐮𝐫 𝐬𝐩𝐨𝐭 𝐭𝐨𝐝𝐚𝐲! Ratnesh Jain | Prajakta Dandekar | Institute Of Chemical Technology | Nanomedicine Research Group, ICTMumbai | Mumbai Biocluster | Jaidev Bhatt | Preeti Kaushik | Anushka Chaudhari

    View organization page for Biologics Workshop, graphic

    8,952 followers

    We’re thrilled to welcome Amita Goel, CEO of Celltheon Corporation as a speaker at 𝐁𝐢𝐨𝐥𝐨𝐠𝐢𝐜𝐬 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 2025 in our session on ‘𝐂𝐞𝐥𝐥 𝐋𝐢𝐧𝐞 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭: 𝐃𝐫𝐢𝐯𝐢𝐧𝐠 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧 𝐟𝐫𝐨𝐦 𝐄𝐧𝐠𝐢𝐧𝐞𝐞𝐫𝐢𝐧𝐠 𝐭𝐨 𝐌𝐚𝐧𝐮𝐟𝐚𝐜𝐭𝐮𝐫𝐢𝐧𝐠’. Her talk will focus on next-generation #cell engineering technologies with an emphasis on the role of 𝐈𝐧𝐝𝐨-𝐔.𝐒. 𝐩𝐚𝐫𝐭𝐧𝐞𝐫𝐬𝐡𝐢𝐩𝐬 in advancing #biologics development. Join us at #Biologics2025 to gain an in-depth understanding of how #global partnerships are accelerating #breakthroughs in biologics development and paving the way for more accessible #healthcare solutions. #Register today and make the most of this incredible opportunity to engage with #industry leaders and experts shaping the future of #biologics! https://lnkd.in/dSVTT_gT 📅 Save the Date: January 30-31, 2025 📍 Location: Novotel Dona Sylvia Resort, Goa, India 🌴 LAST FEW PASSES LEFT >>> 𝐒𝐞𝐜𝐮𝐫𝐞 𝐲𝐨𝐮𝐫 𝐬𝐩𝐨𝐭 𝐭𝐨𝐝𝐚𝐲! Ratnesh Jain | Prajakta Dandekar | Institute Of Chemical Technology | Nanomedicine Research Group, ICTMumbai | Mumbai Biocluster | Jaidev Bhatt | Preeti Kaushik | Anushka Chaudhari #conference #Networking #Leadership #Biopharma #STEM #cell #clone #dst #india #global #collaboration #invest #innovation #BSW25

  • Hope you found our November 20th webinar on OmniCHO Transient Kit informative, but in case you were unable to attend, you can watch it here (https://lnkd.in/gA28kTpN) on demand to learn how this breakthrough system achieves unprecedented protein yields of up to 4.5g/L. Discover how leading biopharmaceutical companies are leveraging this CHO-K1 platform to accelerate their development timelines while maintaining exceptional product quality across all scales.

    View organization page for Celltheon Corporation, graphic

    2,340 followers

    Introducing the OmniCHO™ Transient Expression Kit, designed to revolutionize preclinical drug development by delivering scalable, high-yield protein production. With yields of over 1 g/L within 5 days or 2g/L in 10-12 days and a cost reduction of up to 30-fold per mg compared to traditional kits, OmniCHO empowers rapid, cost-efficient therapeutic development. Ideal for producing antibodies and hard-to-express proteins, this platform offers a game-changing solution for accelerating research timelines and time to IND. Explore the future of CHO-based expression with Celltheon!" https://lnkd.in/gnvY39Q2 #OmniCHO #Bioprocessing #Celltheon #ProteinProduction #BiotechInnovation

    Celltheon Launches Revolutionary OmniCHO™ Transient Expression Kit

    Celltheon Launches Revolutionary OmniCHO™ Transient Expression Kit

    businesswire.com

  • Please join we go live in 5 minutes.

    View profile for Amita Goel, graphic

    CEO Celltheon

    Please sign into the link below we are going live in 5 minutes. We’re incredibly grateful for the overwhelming response—so many of you have already signed up for tomorrow’s webinar! If you haven’t registered yet, there’s still time. We’d love for you to join us live, but if you can’t make it, don’t worry. Simply let us know, and we’ll provide you with a free link to access the recording at your convenience. This session could be the key to overcoming your challenges in molecule development—whether it’s titer, CQA, yield, scalability for MAbs, bispecifics, nanobodies, fusion proteins, or other complex formats. WEBINAR: 10X Transient Bioproduction with the OmniCHO™ Kit 📅 Date: November 20, 2024 ⏰ Time: 10:00 AM - 11:00 AM PDT 🎤 Host: Celltheon Corporation Why Attend? Are you striving to enhance your drug development workflow? Join us to explore how the CHO-K1-based OmniCHO™ System: Delivers up to 10-fold higher yields without compromising product quality. Seamlessly transitions to the stable Goldilocks™ Transposase Platform for Cell Line Development. Offers solutions directly applicable to GMP protein production at 1L-10L scale. Key Takeaways: ✅ Achieve unprecedented yield improvements. ✅ Save time, labor, and costs in your bioproduction process. ✅ Learn how OmniCHO™ accelerates scalability and efficiency in biotherapeutics development. Register Here: Click to Register Now: https://lnkd.in/gHwJtkTr Once registered, you’ll receive a confirmation email with all the details to join the webinar. We can’t wait to connect and share how OmniCHO™ can transform your bioprocessing workflows! About Celltheon At Celltheon, we are committed to delivering cutting-edge technologies for biotherapeutics development and manufacturing. With innovative platforms like OmniCHO™ and the Goldilocks™ Transposase Stable Platform, we simplify cell line development and bioprocessing, ensuring unmatched yields and efficiency. Partner with us to accelerate your drug development timelines and achieve scalability with ease. We hope to see you there! Don’t miss this opportunity to revolutionize your bioproduction strategies. https://lnkd.in/gHj-aEQU Welcome! You are invited to join a webinar: 10X Transient Bioproduction with the OmniCHO™ Kit. After registering, you will receive a confirmation email about joining the webinar.zoom.us

    Welcome! You are invited to join a webinar: 10X Transient Bioproduction with the OmniCHO™ Kit. After registering, you will receive a confirmation email about joining the webinar.

    Welcome! You are invited to join a webinar: 10X Transient Bioproduction with the OmniCHO™ Kit. After registering, you will receive a confirmation email about joining the webinar.

    zoom.us

  • View profile for Amita Goel, graphic

    CEO Celltheon

    Countdown: Just 1 Day to Go! 🚀 We’re incredibly grateful for the overwhelming response—so many of you have already signed up for tomorrow’s webinar! If you haven’t registered yet, there’s still time. We’d love for you to join us live, but if you can’t make it, don’t worry. Simply let us know, and we’ll provide you with a free link to access the recording at your convenience. This session could be the key to overcoming your challenges in molecule development—whether it’s titer, CQA, yield, scalability for MAbs, bispecifics, nanobodies, fusion proteins, or other complex formats. WEBINAR: 10X Transient Bioproduction with the OmniCHO™ Kit 📅 Date: November 20, 2024 ⏰ Time: 10:00 AM - 11:00 AM PDT 🎤 Host: Celltheon Corporation Why Attend? Are you striving to enhance your drug development workflow? Join us to explore how the CHO-K1-based OmniCHO™ System: Delivers up to 10-fold higher yields without compromising product quality. Seamlessly transitions to the stable Goldilocks™ Transposase Platform for Cell Line Development. Offers solutions directly applicable to GMP protein production at 1L-10L scale. Key Takeaways: ✅ Achieve unprecedented yield improvements. ✅ Save time, labor, and costs in your bioproduction process. ✅ Learn how OmniCHO™ accelerates scalability and efficiency in biotherapeutics development. Register Here: Click to Register Now: https://lnkd.in/gHwJtkTr Once registered, you’ll receive a confirmation email with all the details to join the webinar. We can’t wait to connect and share how OmniCHO™ can transform your bioprocessing workflows! About Celltheon At Celltheon, we are committed to delivering cutting-edge technologies for biotherapeutics development and manufacturing. With innovative platforms like OmniCHO™ and the Goldilocks™ Transposase Stable Platform, we simplify cell line development and bioprocessing, ensuring unmatched yields and efficiency. Partner with us to accelerate your drug development timelines and achieve scalability with ease. We hope to see you there! Don’t miss this opportunity to revolutionize your bioproduction strategies. https://lnkd.in/gHj-aEQU

    Welcome! You are invited to join a webinar: 10X Transient Bioproduction with the OmniCHO™ Kit. After registering, you will receive a confirmation email about joining the webinar.

    Welcome! You are invited to join a webinar: 10X Transient Bioproduction with the OmniCHO™ Kit. After registering, you will receive a confirmation email about joining the webinar.

    zoom.us

  • Counting down we are at day -2. A lot of you have already signed up for the webinar this week on Wednesday. Looks like we have a great audience. We still have space feel free to sign up. Perhaps you will find a solution for the challenges you are currently facing with your molecules- titer/ CQA/ yield/ scalability for Mabs/ Bispecifics/ Nano body/ fusion proteins and many more formats. WEBINAR: 10X Transient Bioproduction with the OmniCHO™ Kit Are you looking to enhance your drug development workflow? Event by Celltheon Corporation November 20, 2024, 10:00AM-11:00 AM PDT Discover how the CHO-K1 based OmniCHO™ System achieves up to 10-fold higher yields while maintaining product quality, seamlessly transitioning to our stable Goldilocks™ Transposase Platform for Cell Line Development. Key Takeaways: * Unprecedented yield improvements * Time, labor, and cost savings in your development process * Direct application to GMP protein solutions * Availability of OmniCHO™ kits at 1L-10L scale You can register in advance at the following link: https://lnkd.in/gHwJtkTr We look forward to connecting and sharing how OmniCHO™ can accelerate your bioprocessing efficiency! About Celltheon Celltheon is dedicated to providing the highest-performing and most cost-effective technologies for biotherapeutics development and commercial manufacturing. Leveraging our expertise in Expression Technologies, we deliver innovative solutions such as the OmniCHO™ platform and the Goldilocks™ Transposase Stable Platform. These tools streamline cell line development and bioprocessing, delivering unparalleled yields and efficiency to accelerate drug development timelines. Committed to innovation and excellence, we partner with clients to ensure optimal outcomes and scalability in their bioproduction processes. https://lnkd.in/gHj-aEQU Welcome! You are invited to join a webinar: 10X Transient Bioproduction with the OmniCHO™ Kit. After registering, you will receive a confirmation email about joining the webinar.zoom.us

    Welcome! You are invited to join a webinar: 10X Transient Bioproduction with the OmniCHO™ Kit. After registering, you will receive a confirmation email about joining the webinar.

    Welcome! You are invited to join a webinar: 10X Transient Bioproduction with the OmniCHO™ Kit. After registering, you will receive a confirmation email about joining the webinar.

    zoom.us

  • View profile for Amita Goel, graphic

    CEO Celltheon

    Counting down we are at day -5. A lot of you have already signed up for the webinar next week. Looks like we have a great audience. We still have space feel free to sign up. Perhaps you will find a solution for the challenges you are currently facing with your molecules- titer/ CQA/ yield/ scalability for Mabs/ Bispecifics/ Nano body/ fusion proteins and many more formats. WEBINAR: 10X Transient Bioproduction with the OmniCHO™ Kit Are you looking to enhance your drug development workflow? Event by Celltheon Corporation November 20, 2024, 10:00AM-11:00 AM PDT Discover how the CHO-K1 based OmniCHO™ System achieves up to 10-fold higher yields while maintaining product quality, seamlessly transitioning to our stable Goldilocks™ Transposase Platform for Cell Line Development. Key Takeaways: * Unprecedented yield improvements * Time, labor, and cost savings in your development process * Direct application to GMP protein solutions * Availability of OmniCHO™ kits at 1L-10L scale You can register in advance at the following link: https://lnkd.in/gHwJtkTr We look forward to connecting and sharing how OmniCHO™ can accelerate your bioprocessing efficiency! About Celltheon Celltheon is dedicated to providing the highest-performing and most cost-effective technologies for biotherapeutics development and commercial manufacturing. Leveraging our expertise in Expression Technologies, we deliver innovative solutions such as the OmniCHO™ platform and the Goldilocks™ Transposase Stable Platform. These tools streamline cell line development and bioprocessing, delivering unparalleled yields and efficiency to accelerate drug development timelines. Committed to innovation and excellence, we partner with clients to ensure optimal outcomes and scalability in their bioproduction processes. https://lnkd.in/gHj-aEQU

    Welcome! You are invited to join a webinar: 10X Transient Bioproduction with the OmniCHO™ Kit. After registering, you will receive a confirmation email about joining the webinar.

    Welcome! You are invited to join a webinar: 10X Transient Bioproduction with the OmniCHO™ Kit. After registering, you will receive a confirmation email about joining the webinar.

    zoom.us

  • Celltheon Corporation reposted this

    Join us on November 20, 2024, 10:00AM Pacific Time to learn how OmniCHO™ saves you time, labor and cost in your drug development programs! The CHO-K1 based OmniCHO™ Transient Expression System delivers up to 10-fold higher yields while maintaining product quality attributes that seamlessly translate to stable cell line development. For further details and registration: https://lnkd.in/g4aWd-PS

    WEBINAR: 10X Transient Bioproduction with the OmniCHO™ Kit

    WEBINAR: 10X Transient Bioproduction with the OmniCHO™ Kit

    www.linkedin.com

  • Join us on November 20, 2024, 10:00AM Pacific Time to learn how OmniCHO™ saves you time, labor and cost in your drug development programs! The CHO-K1 based OmniCHO™ Transient Expression System delivers up to 10-fold higher yields while maintaining product quality attributes that seamlessly translate to stable cell line development. For further details and registration: https://lnkd.in/g4aWd-PS

    WEBINAR: 10X Transient Bioproduction with the OmniCHO™ Kit

    WEBINAR: 10X Transient Bioproduction with the OmniCHO™ Kit

    www.linkedin.com

  • Celltheon Corporation reposted this

    We’re excited to announce our new partnership with Scorpius Holdings, a leading CDMO based in San Antonio, Texas! 🎉 Through this collaboration, Celltheon will provide Scorpius and its clients with our innovative OmniCHO Transient and Goldilocks Transposase technologies and services, designed to accelerate preclinical development and streamline cell line development timelines. Together, we’re committed to helping bring new medicines to patients faster and more efficiently. Looking forward to working with the talented team at Scorpius as we push the boundaries of therapeutic innovation! 💊💡 hashtag #Celltheon hashtag #ScorpiusHoldings hashtag #Biotech hashtag #CDMO hashtag #CellLineDevelopment hashtag #DrugDevelopment hashtag #OmniCHO hashtag #GoldilocksTransposase hashtag #Partnerships hashtag #Innovation Scorpius Holdings Announces Collaboration with Celltheon Corporation, a U.S.-Based Cell Line Development Company; First Client Signed Under New Partnership https://lnkd.in/gKTbnaPg https://lnkd.in/g8CjnwkA

  • Celltheon Corporation reposted this

    View profile for Amita Goel, graphic

    CEO Celltheon

    WEBINAR: 10X Transient Bioproduction with the OmniCHO™ Kit Are you looking to enhance your drug development workflow? Event by Celltheon Corporation November 20, 2024, 10:00AM-11:00 AM PDT Discover how the CHO-K1 based OmniCHO™ System achieves up to 10-fold higher yields while maintaining product quality, seamlessly transitioning to our stable Goldilocks™ Transposase Platform for Cell Line Development. Key Takeaways: * Unprecedented yield improvements * Time, labor, and cost savings in your development process * Direct application to GMP protein solutions * Availability of OmniCHO™ kits at 1L-10L scale You can register in advance at the following link: https://lnkd.in/gHwJtkTr We look forward to connecting and sharing how OmniCHO™ can accelerate your bioprocessing efficiency! About Celltheon Celltheon is dedicated to providing the highest-performing and most cost-effective technologies for biotherapeutics development and commercial manufacturing. Leveraging our expertise in Expression Technologies, we deliver innovative solutions such as the OmniCHO™ platform and the Goldilocks™ Transposase Stable Platform. These tools streamline cell line development and bioprocessing, delivering unparalleled yields and efficiency to accelerate drug development timelines. Committed to innovation and excellence, we partner with clients to ensure optimal outcomes and scalability in their bioproduction processes. https://lnkd.in/ge3G43dN

    Welcome! You are invited to join a webinar: 10X Transient Bioproduction with the OmniCHO™ Kit. After registering, you will receive a confirmation email about joining the webinar.

    Welcome! You are invited to join a webinar: 10X Transient Bioproduction with the OmniCHO™ Kit. After registering, you will receive a confirmation email about joining the webinar.

    zoom.us

Similar pages

Funding

Celltheon Corporation 1 total round

Last Round

Series unknown

US$ 200.0K

See more info on crunchbase